Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05544513 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Oral Iron Supplementation for Patients With Chronic Kidney Disease

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv4
  2. Primary completion date: Dec 29, 2023 to Dec 29, 2026
    • Interventions: Ferrous sulfate (Drug) to Ferrous sulfate 3 days week (Drug), Ferrous sulfate daily (Drug), Ferrous sulfate higher concentration (Drug)
    v3
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The hypothesis of this research is that oral iron prescribed in a single dose in alternate day could mitigate the side effects with regard to intestinal microbiota, inflammation, oxidative stress and improve the hematological profile when compared to daily oral iron prescription
Trial Details
NCT Number NCT05544513
Lead Sponsor Universidade Federal Fluminense
Conditions
(from sponsor)		 Chronic Renal Disease, Iron-Deficiency Anemia, Anemia of Chronic Kidney Disease, Dysbiosis
Related terms Anemia, Iron-Deficiency, Dysbiosis, Inflammation, Renal Insufficiency, Chronic
Enrollment 6 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov